# Victory Capital Holdings, Inc.: financial statements, quarterly

VCTR · Nasdaq · CIK 1570827 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vctr.md) · [Financials](/companies/vctr/financials.md) · [Filings](/companies/vctr/filings.md) · [Insiders](/companies/vctr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/vctr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [210](/filings/0000950170-24-123762.md) | [206 d](/filings/0001193125-26-077057.md) | [216](/filings/0000950170-25-067558.md) | [220](/filings/0000950170-25-105496.md) | [226](/filings/0001193125-25-271198.md) | [232 d](/filings/0001193125-26-077057.md) | [220](/filings/0001193125-26-210575.md) | [351](/filings/0001193125-26-337010.md) | [361](/filings/0001193125-25-271198.md) | [374 d](/filings/0001193125-26-077057.md) | [388](/filings/0001193125-26-210575.md) | [435](/filings/0001193125-26-337010.md) |
| Operating income | $m | [80.0](/filings/0000950170-24-123762.md) | [86.3 d](/filings/0001193125-26-077057.md) | [84.8](/filings/0000950170-25-067558.md) | [111](/filings/0000950170-25-105496.md) | [120](/filings/0001193125-25-271198.md) | [112 d](/filings/0001193125-26-077057.md) | [92.9](/filings/0001193125-26-210575.md) | [94.2](/filings/0001193125-26-337010.md) | [138](/filings/0001193125-25-271198.md) | [153 d](/filings/0001193125-26-077057.md) | [159](/filings/0001193125-26-210575.md) | [194](/filings/0001193125-26-337010.md) |
| Income tax | $m | [13.9](/filings/0000950170-24-123762.md) | [18.3 d](/filings/0001193125-26-077057.md) | [16.2](/filings/0000950170-25-067558.md) | [21.5](/filings/0000950170-25-105496.md) | [25.5](/filings/0001193125-25-271198.md) | [21.7 d](/filings/0001193125-26-077057.md) | [18.4](/filings/0001193125-26-210575.md) | [28.3](/filings/0001193125-26-337010.md) | [32.7](/filings/0001193125-25-271198.md) | [28.8 d](/filings/0001193125-26-077057.md) | [35.7](/filings/0001193125-26-210575.md) | [47.8](/filings/0001193125-26-337010.md) |
| Net income | $m | [52.0](/filings/0000950170-24-123762.md) | [55.2 d](/filings/0001193125-26-077057.md) | [55.7](/filings/0001193125-25-271198.md) | [74.3](/filings/0001193125-25-271198.md) | [82.0](/filings/0001193125-25-271198.md) | [76.9 d](/filings/0001193125-26-077057.md) | [62.0](/filings/0001193125-26-337010.md) | [58.7](/filings/0001193125-26-337010.md) | [96.5](/filings/0001193125-25-271198.md) | [113 d](/filings/0001193125-26-077057.md) | [112](/filings/0001193125-26-337010.md) | [139](/filings/0001193125-26-337010.md) |
| Diluted EPS | $ per share | [0.77](/filings/0000950170-24-123762.md) | not reported | [0.84](/filings/0000950170-25-067558.md) | [1.12](/filings/0000950170-25-105496.md) | [1.24](/filings/0001193125-25-271198.md) | not reported | [0.96](/filings/0001193125-26-210575.md) | [0.68](/filings/0001193125-26-337010.md) | [1.11](/filings/0001193125-25-271198.md) | not reported | [1.33](/filings/0001193125-26-210575.md) | [1.68](/filings/0001193125-26-337010.md) |
| Basic EPS | $ per share | [0.79](/filings/0000950170-24-123762.md) | not reported | [0.86](/filings/0000950170-25-067558.md) | [1.15](/filings/0000950170-25-105496.md) | [1.26](/filings/0001193125-25-271198.md) | not reported | [0.97](/filings/0001193125-26-210575.md) | [0.69](/filings/0001193125-26-337010.md) | [1.12](/filings/0001193125-25-271198.md) | not reported | [1.34](/filings/0001193125-26-210575.md) | [1.70](/filings/0001193125-26-337010.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [108](/filings/0000950170-23-058750.md) | [124](/filings/0000950170-25-029770.md) | [79.9](/filings/0000950170-24-057507.md) | [119](/filings/0000950170-24-094388.md) | [188](/filings/0000950170-24-123762.md) | [127](/filings/0001193125-26-077057.md) | [176](/filings/0000950170-25-067558.md) | [108](/filings/0000950170-25-105496.md) | [116](/filings/0001193125-25-271198.md) | [164](/filings/0001193125-26-337010.md) | [75.8](/filings/0001193125-26-210575.md) | [70.1](/filings/0001193125-26-337010.md) |
| Total assets | $m | [2,592](/filings/0000950170-23-058750.md) | [2,543](/filings/0000950170-25-029770.md) | [2,506](/filings/0000950170-24-057507.md) | [2,541](/filings/0000950170-24-094388.md) | [2,612](/filings/0000950170-24-123762.md) | [2,548](/filings/0001193125-26-077057.md) | [2,583](/filings/0000950170-25-067558.md) | [4,249](/filings/0000950170-25-105496.md) | [4,212](/filings/0001193125-25-271198.md) | [4,248](/filings/0001193125-26-337010.md) | [4,142](/filings/0001193125-26-210575.md) | [4,175](/filings/0001193125-26-337010.md) |
| Total liabilities | $m | [1,516](/filings/0000950170-23-058750.md) | [1,490](/filings/0000950170-25-029770.md) | [1,429](/filings/0000950170-24-057507.md) | [1,418](/filings/0000950170-24-094388.md) | [1,437](/filings/0000950170-24-123762.md) | [1,426](/filings/0001193125-26-077057.md) | [1,439](/filings/0000950170-25-067558.md) | [1,784](/filings/0000950170-25-105496.md) | [1,813](/filings/0001193125-25-271198.md) | [1,823](/filings/0001193125-26-337010.md) | [1,782](/filings/0001193125-26-210575.md) | [1,800](/filings/0001193125-26-337010.md) |
| Long-term debt | $m | [988](/filings/0000950170-23-058750.md) | [989](/filings/0000950170-25-029770.md) | [990](/filings/0000950170-24-057507.md) | [982](/filings/0000950170-24-094388.md) | [983](/filings/0000950170-24-123762.md) | [964](/filings/0001193125-26-077057.md) | [965](/filings/0000950170-25-067558.md) | [966](/filings/0000950170-25-105496.md) | [972](/filings/0001193125-25-271198.md) | [970](/filings/0001193125-26-337010.md) | [968](/filings/0001193125-26-210575.md) | [968](/filings/0001193125-26-337010.md) |
| Shareholders' equity | $m | [1,076](/filings/0000950170-24-123762.md) | [1,053](/filings/0001193125-26-077057.md) | [1,077](/filings/0001193125-25-271198.md) | [1,123](/filings/0001193125-25-271198.md) | [1,175](/filings/0001193125-25-271198.md) | [1,122](/filings/0001193125-26-337010.md) | [1,145](/filings/0001193125-26-337010.md) | [2,465](/filings/0001193125-26-337010.md) | [2,399](/filings/0001193125-25-271198.md) | [2,425](/filings/0001193125-26-337010.md) | [2,360](/filings/0001193125-26-337010.md) | [2,375](/filings/0001193125-26-337010.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [91.6 d](/filings/0000950170-24-123762.md) | [97.1 d](/filings/0001193125-26-077057.md) | [68.7](/filings/0000950170-25-067558.md) | [79.7 d](/filings/0000950170-25-105496.md) | [99.8 d](/filings/0001193125-25-271198.md) | [91.8 d](/filings/0001193125-26-077057.md) | [81.1](/filings/0001193125-26-210575.md) | [(6.6) d](/filings/0001193125-26-337010.md) | [166 d](/filings/0001193125-25-271198.md) | [145 d](/filings/0001193125-26-077057.md) | [121](/filings/0001193125-26-210575.md) | [135 d](/filings/0001193125-26-337010.md) |
| Capital expenditure | $m | [1.8 d](/filings/0000950170-24-123762.md) | [0.8 d](/filings/0001193125-26-077057.md) | [0.5](/filings/0000950170-25-067558.md) | [0.2 d](/filings/0000950170-25-105496.md) | [0.4 d](/filings/0001193125-25-271198.md) | [0.2 d](/filings/0001193125-26-077057.md) | [1.6](/filings/0001193125-26-210575.md) | [0.9 d](/filings/0001193125-26-337010.md) | [1.1 d](/filings/0001193125-25-271198.md) | [0.6 d](/filings/0001193125-26-077057.md) | [0.8](/filings/0001193125-26-210575.md) | [1.2 d](/filings/0001193125-26-337010.md) |
| Dividends paid | $m | [21.2 d](/filings/0000950170-24-123762.md) | [20.7 d](/filings/0001193125-26-077057.md) | [22.4](/filings/0000950170-25-067558.md) | [24.0 d](/filings/0000950170-25-105496.md) | [26.6](/filings/0001193125-25-271198.md) | [28.1 d](/filings/0001193125-26-077057.md) | [29.9](/filings/0001193125-26-210575.md) | [43.7 d](/filings/0001193125-26-337010.md) | [42.1](/filings/0001193125-25-271198.md) | [41.3 d](/filings/0001193125-26-077057.md) | [41.6](/filings/0001193125-26-210575.md) | [41.1 d](/filings/0001193125-26-337010.md) |
| Share repurchases | $m | [1.9 d](/filings/0000950170-24-123762.md) | [57.5 d](/filings/0001193125-26-077057.md) | [2.9](/filings/0000950170-25-067558.md) | [2.1 d](/filings/0000950170-25-105496.md) | [1.6 d](/filings/0001193125-25-271198.md) | [96.9 d](/filings/0001193125-26-077057.md) | [0.5](/filings/0001193125-26-210575.md) | [26.0 d](/filings/0001193125-26-337010.md) | [119 d](/filings/0001193125-25-271198.md) | [50.7 d](/filings/0001193125-26-077057.md) | [127](/filings/0001193125-26-210575.md) | [91.4 d](/filings/0001193125-26-337010.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [71.9](/filings/0000950170-23-058750.md) | [69.7](/filings/0000950170-24-057507.md) | [68.5](/filings/0000950170-24-094388.md) | [67.7](/filings/0000950170-24-123762.md) | [66.0](/filings/0000950170-25-067558.md) | [66.1](/filings/0000950170-25-105496.md) | [66.1](/filings/0001193125-25-271198.md) | [64.7](/filings/0001193125-26-210575.md) | [68.0](/filings/0001193125-26-337010.md) | [67.0](/filings/0001193125-25-271198.md) | [64.4](/filings/0001193125-26-210575.md) | [62.8](/filings/0001193125-26-337010.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 61,509,572 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337010.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.